Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Aug;80(11):1838–1843. doi: 10.1038/sj.bjc.6690608

Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan

C-S Huang 1, C-Y Shen 4, K-J Chang 1, S-M Hsu 3, H-D Chern 3
PMCID: PMC2363117  PMID: 10468307

Abstract

The incidence of breast cancer has been greatly increasing in Taiwan over the past two decades. Since cytochrome P4501A1 (CYP1A1) is involved in the metabolism of environmental carcinogens or oestrogen, we hypothesized that CYP1A1 genetic polymorphism may be a susceptibility factor for breast cancer. This hypothesis was evaluated in this case control study of 150 breast cancer patients and 150 healthy controls among Chinese women. Two CYP1A1 polymorphisms were studied, one containing a new Msp1 site and the other located in axon 7 and resulting in the replacement of an isoleucine (Ile) residue by a valine (Val). After simultaneously considering the known or significant risk factors for breast cancer, including the age of study participants, positive family history of breast cancer, early menarche (≤ 13 years), nulliparity and late first full-term pregnancy (≥ 30 years), hormone replacement therapy and smoking, the CYP1A1 Msp1 polymorphism was found to be a significant factor in determining the risk of breast cancer. The homozygous variant was the most susceptible genotype with an adjusted odds ratio of 1.98 (95% confidence interval (CI) = 1.01–3.99) compared with the non-homozygous variants (the homozygous wild-type and the heterozygous variant). In contrast, the CYP1A1 Ile/Val polymorphism was not significantly associated with breast cancer development (adjusted OR = 1.07, 95% CI = 0.64–1.78). Interestingly, the Msp1 polymorphism was especially significant in postmenopausal women, but not in premenopausal women. Further stratification analysis in postmenopausal women who were non-smokers and with no history of hormone replacement therapy showed the cancer risk due to the Msp1 variant to be more significant in women with early menarche. We conclude that CYP1A1 polymorphism is a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Further study with a large sample size should be considered to address issues of interactions between CYP1A1 and other risk factors. © 1999 Cancer Research Campaign

Keywords: CYP1A1, genetic polymorphism, susceptibility, breast cancer

Full Text

The Full Text of this article is available as a PDF (86.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandrie A. K., Sundberg M. I., Seidegård J., Tornling G., Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994 Sep;15(9):1785–1790. doi: 10.1093/carcin/15.9.1785. [DOI] [PubMed] [Google Scholar]
  2. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J. R., Vena J. E., Brasure J. R., Laughlin R., Nemoto T., Michalek A. M., Harrington A. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 1995 Aug 15;55(16):3483–3485. [PubMed] [Google Scholar]
  3. Bailey L. R., Roodi N., Verrier C. S., Yee C. J., Dupont W. D., Parl F. F. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res. 1998 Jan 1;58(1):65–70. [PubMed] [Google Scholar]
  4. Ball S. E., Forrester L. M., Wolf C. R., Back D. J. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes. Biochem J. 1990 Apr 1;267(1):221–226. doi: 10.1042/bj2670221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bernstein L., Yuan J. M., Ross R. K., Pike M. C., Hanisch R., Lobo R., Stanczyk F., Gao Y. T., Henderson B. E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control. 1990 Jul;1(1):51–58. doi: 10.1007/BF00053183. [DOI] [PubMed] [Google Scholar]
  6. Chie W. C., Li C. Y., Huang C. S., Chang K. J., Lin R. S. Body size as a factor in different ages and breast cancer risk in Taiwan. Anticancer Res. 1998 Jan-Feb;18(1B):565–570. [PubMed] [Google Scholar]
  7. Drakoulis N., Cascorbi I., Brockmöller J., Gross C. R., Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region. Clin Investig. 1994 Feb;72(3):240–248. doi: 10.1007/BF00189321. [DOI] [PubMed] [Google Scholar]
  8. Fishman J., Schneider J., Hershcope R. J., Bradlow H. L. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem. 1984 Apr;20(4B):1077–1081. doi: 10.1016/0022-4731(84)90021-9. [DOI] [PubMed] [Google Scholar]
  9. Hayashi S., Watanabe J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem. 1991 Sep;110(3):407–411. doi: 10.1093/oxfordjournals.jbchem.a123594. [DOI] [PubMed] [Google Scholar]
  10. Hirvonen A., Husgafvel-Pursiainen K., Karjalainen A., Anttila S., Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):485–489. [PubMed] [Google Scholar]
  11. Hunter D. J., Willett W. C. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15(1):110–132. doi: 10.1093/oxfordjournals.epirev.a036096. [DOI] [PubMed] [Google Scholar]
  12. Ishibe N., Hankinson S. E., Colditz G. A., Spiegelman D., Willett W. C., Speizer F. E., Kelsey K. T., Hunter D. J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res. 1998 Feb 15;58(4):667–671. [PubMed] [Google Scholar]
  13. Kato S., Bowman E. D., Harrington A. M., Blomeke B., Shields P. G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst. 1995 Jun 21;87(12):902–907. doi: 10.1093/jnci/87.12.902. [DOI] [PubMed] [Google Scholar]
  14. Kawajiri K., Nakachi K., Imai K., Watanabe J., Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol. 1993 Feb;14(1):77–87. doi: 10.1016/1040-8428(93)90007-q. [DOI] [PubMed] [Google Scholar]
  15. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 1990 Apr 9;263(1):131–133. doi: 10.1016/0014-5793(90)80721-t. [DOI] [PubMed] [Google Scholar]
  16. Kelsey J. L., Gammon M. D., John E. M. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47. doi: 10.1093/oxfordjournals.epirev.a036115. [DOI] [PubMed] [Google Scholar]
  17. Kihara M., Kihara M., Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis. 1995 Oct;16(10):2331–2336. doi: 10.1093/carcin/16.10.2331. [DOI] [PubMed] [Google Scholar]
  18. Lo Y. L., Yu J. C., Huang C. S., Tseng S. L., Chang T. M., Chang K. J., Wu C. W., Shen C. Y. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int J Cancer. 1998 Dec 18;79(6):580–587. doi: 10.1002/(sici)1097-0215(19981218)79:6<580::aid-ijc5>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  19. Nakachi K., Imai K., Hayashi S., Watanabe J., Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 1991 Oct 1;51(19):5177–5180. [PubMed] [Google Scholar]
  20. Osborne M. P., Bradlow H. L., Wong G. Y., Telang N. T. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst. 1993 Dec 1;85(23):1917–1920. doi: 10.1093/jnci/85.23.1917. [DOI] [PubMed] [Google Scholar]
  21. Oyama T., Mitsudomi T., Kawamoto T., Ogami A., Osaki T., Kodama Y., Yasumoto K. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health. 1995;67(4):253–256. doi: 10.1007/BF00409407. [DOI] [PubMed] [Google Scholar]
  22. Perera F. P., Estabrook A., Hewer A., Channing K., Rundle A., Mooney L. A., Whyatt R., Phillips D. H. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):233–238. [PubMed] [Google Scholar]
  23. Taioli E., Trachman J., Chen X., Toniolo P., Garte S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 1995 Sep 1;55(17):3757–3758. [PubMed] [Google Scholar]
  24. Xu X., Kelsey K. T., Wiencke J. K., Wain J. C., Christiani D. C. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):687–692. [PubMed] [Google Scholar]
  25. Yager J. D., Liehr J. G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203–232. doi: 10.1146/annurev.pa.36.040196.001223. [DOI] [PubMed] [Google Scholar]
  26. Yang P. S., Yang T. L., Liu C. L., Wu C. W., Shen C. Y. A case-control study of breast cancer in Taiwan--a low-incidence area. Br J Cancer. 1997;75(5):752–756. doi: 10.1038/bjc.1997.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zhang Z. Y., Fasco M. J., Huang L., Guengerich F. P., Kaminsky L. S. Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res. 1996 Sep 1;56(17):3926–3933. [PubMed] [Google Scholar]
  28. Zhu B. T., Conney A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998 Jan;19(1):1–27. doi: 10.1093/carcin/19.1.1. [DOI] [PubMed] [Google Scholar]
  29. Ziegler R. G., Hoover R. N., Pike M. C., Hildesheim A., Nomura A. M., West D. W., Wu-Williams A. H., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993 Nov 17;85(22):1819–1827. doi: 10.1093/jnci/85.22.1819. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES